miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.

Name: miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
Author: Tang, Huaping

miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells. — المؤلف: Tang, Huaping — International journal of molecular medicine 20190520

المؤلف: Tang, Huaping
النشر: International journal of molecular medicine 20190520
الوصف: 1203-1216 p.
الموضوعات: Adult؛ Aged؛ Animals؛ Carcinoma, Non-Small-Cell Lung؛ Cell Cycle؛ Cell Line, Tumor؛ Cell Movement؛ Cell Proliferation